ARCHIVES

Hammer Says “Exciting Times” Should Convince President to Increase Budget, Ok Act Renewal

This article is from The Cancer Letter archive.

Vol. 11 No. 17 | April 26, 1985

Download PDF Visit The Full Archive

Related Articles

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

Switch To NTP Holds Down Entry Of New Compounds; Obey Supports NCI On Need For More Positions

March 16, 1979

In Brief: HEW Opposes Research Contract Peer review; Congressman Blass Inadequate Grant Funds

May 10, 1974

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Alliteration And Prayer Were Andrew von Eschenbach’s Tools For Making Progress Possible For People.

May 19, 2006

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011